Trial Profile
Pharmacokinetic and pharmacodynamic study comparing two different dosages of Thymoglobuline in renal transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms THYMO
- 22 Jul 2021 Results of pharmacokinetic-pharmacodynamic modelling of EudraCT2009-012673-35, published in the Clinical Pharmacokinetics.
- 08 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
- 08 Sep 2013 Status changed from recruiting to completed.